ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at three upcoming investor conferences:
- The Raymond James & Associates' 40th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 5, 2019, at 2:50 p.m. (Eastern Time).
- The Cowen and Company 39th Annual Health Care Conference in Boston, Massachusetts on Tuesday, March 12, 2019, at 12:00 p.m. (Eastern Time).
- The Barclays Global Healthcare Conference in Miami, Florida on Thursday, March 14, 2019, at 8:30 a.m. (Eastern Time).
To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com. Replays of the webcasts will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. Founded in 2000, Insulet has more than 150,000 users across the globe who rely on its Omnipod Insulin Management System to bring simplicity and freedom to their lives.